Sponsor
Navire Pharma Inc.
1800 Owens Street Floor 12th, 94158-2388, United States
About the sponsor
Navire Pharma Inc. focuses on advanced solid tumors with a particular interest in metastatic disease and tumor-driven molecular subtypes. Its clinical work centers on cancers defined by the KRAS-G12C mutation, reflecting an emphasis on precision-targeted treatment strategies in difficult-to-treat malignancies.
- Advanced or metastatic solid tumors
- Molecularly defined cancer populations
- KRAS-G12C-mutant malignancies
The sponsor’s research interest extends across multiple tumor types that share a common oncogenic alteration, with a clear therapeutic focus on mutation-directed cancer therapy.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.